While the antibody response to influenza vaccines has been the main focus of protection, a cell-mediated immune (CMI) response, in particular CD4+ and CD8+ T-cells, towards the well-conserved internal influenza nucleoprotein (NP) could be an alternative and complementary path for protection. This evidence concerns the gene CD4 and influenza.